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LETTERS TO 
THE EDITOR
Reply to the commentary 
on Decruyenaere et al 
“Adolescents’ opinions 
about genetic risk 
information, prenatal 
diagnosis, and pregnancy 
termination”
As psychologists, we are convinced that our 
discipline has at least three important roles 
in the field of clinical genetics: (1) par­
ticipation in counselling aimed at free, in­
formed decision maldng and at coping better 
with the genetic risk or the result of genetic 
testing; (2) description of psychological pro­
files of patients with a specific genetic dis­
ease, including neuropsychological testing; 
(3) research to obtain insight into people’s 
knowledge, beliefs, feelings, and behaviour 
related to genetic disease^ genetic risk, and 
genetic testing. “Prediction” of how many 
people will use specific genetic tests and de­
lineation of predictor variables is part of the 
latter role.
We want to stress that the mere prediction 
of future uptake rates or other preventive 
behaviour is not the main purpose of our 
study. The study is aimed at a description of 
adolescents’ present opinions about genetic 
risk informations prenatal diagnosis;, and 
pregnancy termination, as a starting point for 
setting up an information campaign: “To gain 
further insight . . . genetic testing” (see Ab­
stract). It does not lead to the conclusion that 
adolescents show an apparent lack of interest 
in genetic information. Indeed, one should 
not extrapolate from other findings about the 
gap between “intentions and real uptake for 
specific predictive tests or carrier tests” to 
conclude that adolescents’ self-reported at­
titudes are an “overestimation o f  future de­
m and” . In this study it may as well be an 
underestimation, because of the age of the 
respondents and their lack of experience of 
life. This may be particularly true with regard 
to pregnancy termination. Our interpretation 
of the findings of the study is that “Ado­
lescents in Flanders are interested in being 
informed about genetic risks and genetic dis­
eases and in making use of prenatal diagnosis 
because they want to make informed re­
productive decisions in the future and to 
be emotionally prepared for the birth of an 
affected child” (see Abstract).
The comment that “these results would 
not apply in countries where fewer people 
have religious objections to abortion” can be 
questioned. Although the large majority of 
the population in Flanders is Rom an Cath­
olic, less than 15% of the adolescents reported 
that they attend church regularly or very fre­
quently. Therefore we think that tiieir ob­
jections to pregnancy termination are not 
purely religious but that they stem from more 
general negative feelings towards abortion. 
The commentator’s objection that “we do 
not know what they understood by a severe 
genetic disorder” has been dealt with in the
discussion of the paper. The adolescents may 
indeed have had completely different con­
ditions in mind during the interview. The 
main point of interest, however, is their "sub­
jective perception” of a serious situation.
At the end of the comment the following 
question is raised: “To what extent do we 
have a responsibility to provide information 
that people will not want to act on?” . 
This question is misleading. “Genetic in­
formation” and “ acting on information” 
should not be narrowed to decision maldng 
concerning a pregnancy termination. The in­
formation in education campaigns may elicit 
different types of actions: seeking additional 
information about genetic risks, refraining 
from having children, opting for prenatal 
diagnosis, a predictive test, or a carrier 
t e s t . . .  or deciding not to use the information. 
Indeed, the main aim of education campaigns 
associated with hum an genetics is to allow 
people to make free informed choices and 
genetic centres as well as policy makers have 
a responsibility in this field. In this respect 
die finding that adolescents develop a critical 
attitude when confronted with information 
about genetic diseases and genetic counselling 
is positive. Moreover, creating awareness of 
the psychological and ethical issues connected 
with genetic technology should be part of 
any information campaign concerning human 
genetics.
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Glycogen storage disease 
type II: frequency of three 
common mutant alleles 
and their associated 
clinical phenotypes 
studied in 121 patients
Glycogen storage disease type II (GSD II, 
acid maltase deficiency, Pompe disease) is an 
autosomal recessive trait caused by a de­
ficiency of lysosomal a-glucosidase, leading 
to a characteristic accumulation of glycogen 
in lysosomes. Otiier types of glycogenosis are 
distinguished by cytoplasmic glycogen ac­
cumulation. Three clinical phenotypes are 
recognised: “infantile” (severe myopathy and
694/692
N M N M
Identification of the wild type and 
IV S 1 (— 13T-+G) (Aexon2) alleles by ARM S. 
The normal allele (N) is amplified using 
5TCC CTG C TG TAG C CC G CTTT3' as sense 
and 5'ACCCCAAGCTTGTGAGGTGC3' as 
antisense primer. The mutant allele (M) is 
amplified using the same antisense primer and 
5'CCTGCTGTAGCCCGCTTG3’ as sense 
primer. The melting temperature for each primer 
was the same (64°C). The PCR mixture 
consisted of: 20 mmolll Tris-HCl (pH 8-4),
50 mmottl KCl3 1 ¡imolU MgCl2i 10%
DMSOy 0'005% iV-1} 250 mmolll of each 
dNTP, 1 ¡.miolU of each pnmer3 0'5 fig template 
D N A , and 2'5 units Taq D NA polymerase in 
a fina l volume of 50 ¡iL The PCR conditions 
were: 5 mimttes at 94°C3 5 minutes at 59° C3 
and 5 minutes at 72°C (one cycle) followed by
2 minutes at 94° C3 2 minutes at 59aC
3 minutes at 72°C (33 cycles)3 and ending 
with 10 minutes at 72° C. The fragments were 
analysed by 1‘5% agawse gel electrophoresis. 
Lanes 1 and 23 homozygote for wild type allele. 
Lanes 3 and 4S hetewsygote for
IV S l ( — 1 3 T ^G ) allele. M } marker.
cardiomyopadiy with early onset and rapid 
progression usually leading to death within 
one year), “juvenile”, and “adult” (myopathy 
with delayed onset and slow progression, no 
cardiac involvement).
Among the mutations recently discovered 
in the a-glucosidase gene,1 three occur with 
increased frequency: a base substitution in 
intron 1 ( — 13T->G) leading to the aberrant 
splicing of exon 2 (IVS1(— 13T->G)),2 the 
deletion of exon 18 (AexonlS),34 and the 
deletion of a single base (AT525) leading 
to premature termination of a-glucosidase 
synthesis.5 Here we report the occurrence of 
these mutations in 121 patients and compare 
their frequency in infantile, juvenile, and adult 
GSD II, in Dutch and non-Dutch popu­
lations. The methods for mutation detection 
were the following. The Aexon 18 and the 
AT525 alleles were identified as recently de­
scribed by Van der Kraan et al3 and Hermans
Table 1 M utant allele frequency in glycogen storage disease type I I
Clinical phenotype No of patients Allele frequency
IV S 1 (-!3 T -» G ) AT525 Aexon 18
26* 0-00 0-35 0*31
Infantile 58 0.00 0.16 0.15
32f 0-00 0*00 0-02
8 0-19 0*19 0-00
Juvenile 13 0-15 0*15 0-00
5 0-10 0-10 0*00
33 0-46 0*15 0*08
Adult 50 0-38 0*11 0*05
17 0*24 0*03 0*00
* Dutch patients.
+ Non-Dutch patients; among the non-Dutch patients were European (35), Asian (7), African Black (1), 
North African (2), American Black (1), Turkish (6), Lebanese (1), and Cambodian/Finnish (1).
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Table 2 Combinations of mutant alleles in patients with glycogen storage disease type II
Infantile Juvenile Adult a glucosidase activity*
rVSl(-13T->G)/rVSl(-13T->G) — — v
AT525/AT525 5 — ---- <1
Aexonl8/Aexonl8 2 — — <1
Àexonl8/ÀT525 4 — — <1
IVS1( —13T -* G)/Aexon 18 — — 5 11-3-16-0
1VS1 ( — 13T ->-G)/AT525 — 1 1 0 9 - 1 - 2 0
* ct-glucosidase activity in cultured fibroblasts as % of the mean of normal controls.
et aly respectively. To identify the 
IVS1 ( — 13T--+G) mutation, two PC R  primer 
sets were designed, based on the amplification 
refractory mutation system (ARMS) de­
scribed by Newton et a l b T he  first set amp­
lifies specifically the wild type allele, the 
second set the IVS1(—13T-*G) allele (fig­
ure). The frequencies of the three mutant 
alleles are given in table 1.
Our data confirm those of Huie et al2 who 
found that IVS1(— 13T->G) is a frequent 
mutation in adult GSD II, but is not as­
sociated with infantile GSD II. Further, we 
have shown the IVS1(—13T->G) mutation 
in juvenile GSD II. The mutation was not 
encountered in a total of 54 unrelated con­
trols. The other two mutations are not re­
stricted to certain phenotypes and are more 
frequent in the Dutch than in other patient 
populations. This could be the result of a 
founder effect.
By screening for these three mutations, 
we succeeded in identifying one mutant a 
glucosidase allele in 42 of 121 patients (35% 
of the total and 49% of the Dutch patient 
population). In an additional 27 patients, 
both alleles were identified (22% of the total 
and 39% of the Dutch patient population) 
allowing a genotype-phenotype correlation to 
be made (table 2).
Homozygotes for Aexonl8 or AT525 and 
compound heterozygotes for these mutant 
alleles have the infantile form of GSD II and 
no a-glucosidase activity. In contrast, patients 
with either Aexonl8 or AT525 in com­
bination with IVS1(— 13T->G) have the ju­
venile (one patient) or the adult (15 patients) 
phenotype and have 10 to 20% of the mean 
a-glucosidase activity in normal controls, sug­
gesting that IVS 1 ( — 13T-> G) is a mild muta­
tion allowing a-glucosidase synthesis and 
function at 20-40% of the normal level. 
Homozygotes for IVS 1 ( — 13T->G) were not 
encountered, possibly because the residual 
activity in these subjects prevents clinical 
signs.
We propose that these data are good evid­
ence of genotype-phenotype correlations in 
GSD II and suggest that genotype analysis 
may complement routine (prenatal) diag- . 
nosis, particularly when common mutations 
can be identified. Further, carrier detection in 
couples at risk becomes a practicable option.
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Partial trisomy 3q and the 
mild Cornelia de Lange 
syndrome phenotype
The article published by Holder et al1 de­
scribed two children whose facial features
were very similar to children widi mild de 
Lange syndrome. Cytogenetic analysis 
showed them to be trisomic for the region 
3q25 .1-26.2 as a result of inheriting an un­
balanced interchromosomal insertion from 
their father who was a balanced insertion 
carrier. Fluorescence in situ hybridisation 
(FISH) studies using chromosome 3 paint 
confirmed that the insertion on chromosome 
10 had originated from chromosome 3.
We were particularly interested in these 
children both because their phenotypes over­
lapped with that seen in mild de Lange syn­
drome and because they were duplicated for 
a very small region of chromosome 3. We had 
previously reported a child with Cornelia de 
Lange syndrome and a de novo translocation, 
t(3;17)(q26.3;q23.1)2. Before the identi­
fication of this patient it had been thought 
that the de Lange gene may map to 3q because 
o f  phenotypic overlap with subjects who were 
trisomic for variable regions of 3q. These 
people are usually trisomic for large regions 
of 3q and also monosomic for other variable 
regions of the genome. However, the common 
region of overlap in all cases is 3q26.3.
Chromosome 3q has two prominent 
Giemsa bands near the end of the q arm 
which are similar in size and vary only in 
die intensity of staining. T he  children de­
scribed in the report of Holder et al1 were 
thought to be trisomic for the more proximal 
Giemsa band in 3q26, 3q26.1, whereas the 
translocation breakpoint in the patient with 
the de novo translocation disrupts the more 
distal band, 3q26.3. Using a non-chimeric 
yeast artificial chromosome (YAC) clone 
(CEPH 886e7) positive for microsatellite 
marker AFM164tc7 (D3S1548)5 which is 
known from somatic cell hybrid data to map 
to 3q26.3,3 we were able to show that the 
children are trisomic for die more distal of 
the two Giemsa bands on 3q26, that is, 
3q26,3. T he  figure shows metaphase chro­
mosome spreads from one of die children 
hybridised with die biotinylated YAC DNA 
that has been detected with F IT C . In addition 
to two signals from distal 3q there is an 
additional signal on lOq. T he  fact that diese 
children are trisomic for 3q26.3 further con­
firms that 3q26.3 is the 3q duplication critical 
region and that the de Lange syndrome gene 
maps in this area.
Metaphase chromosomes from one of the chtldreny hybridised with probe 886e7 from 
3q26.3. Note three signals are visible, two from 3q26.3 and one from chromosome 10.
